Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawAbortion

Fact Sheet: Government Funding Sources for Planned Parenthood (2013-2015)

To view as PDF, see Fact Sheet: Government Funding Sources of Planned Parenthood

 

According to a data point in Planned Parenthood’s annual report for 2016-2017, the organization received $543.7 million in funds from all levels of government in that fiscal year.[1]  These funds are largely from the U.S. government and primarily from the Medicaid program, which is the primary federal-state program paying for direct medical services to the poor, defined for most purposes as individuals and families with incomes at or below 138% of the federal poverty line (FPL).

 

After Medicaid, the Title X federal family planning program is the second highest government funding stream for Planned Parenthood. In addition, a variety of other federal programs, featuring grants, contracts, and other reimbursement schemes, provide tax dollars to Planned Parenthood.  A Government Accountability Office report released in March 2018 provides a list of the federal programs that provide such funding and allows construction of a table of amounts and rough percentages each conduit provides out of the national total.[2]

 

From 2013 to 2015, Planned Parenthood spent a total of $1.5 billion in federal program funds, including combined federal and state funds under federal programs. Of this total, Planned Parenthood received $1.2 billion in reimbursements from Medicaid, and the remaining $289 million came from various programs under the Department of Health and Human Services as well as the departments of Agriculture, Education, Homeland Security, Housing and Urban Development, and Justice.[3]

 


[1] Available online at https://www.plannedparenthood.org/uploads/filer_public/71/53/7153464c-8f5d-4a26-bead-2a0dfe2b32ec/20171229_ar16-17_p01_lowres.pdf

[2] This information can be found in Enclosure V of the GAO report. The report is in the form of a letter response to Members of Congress; its subject line is “Health Care Funding: Federal Obligations to and Expenditures by Selected Organizations Involved in Health-Related Activities, Fiscal Years 2013-2015”; the report covers Federally Qualified Health Centers and three organizations including the Planned Parenthood Federation of America and its affiliates (Government Accountability Office, GAO-18-204R Federal Funds for Selected Organizations, March 8, 2018) at https://www.gao.gov/assets/700/690490.pdf

[3] CLI’s fact sheet on government funding sources of International Planned Parenthood Federation and Marie Stopes International is also available online here: https://lozierinstitute.org/wp-content/uploads/2018/03/Gvmt-Funding-Internatl-Abortion-Orgs.pdf

[4] See Table 3 of the GAO report, pg. 6.

[5] Each insurance program includes state funds; this federal component shown is overstated.

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined.

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

A person in a white shirt dropping an abortion ballot into a white box against a yellow background.

Abortion on the Ballot in November

October 2, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image